14 results
PRE 14A
ALGS
Aligos Therapeutics Inc
16 Apr 24
Preliminary proxy
5:27pm
Policy, is intended to comply with SEC and Nasdaq listing standards and maintain a culture of focused, diligent, and responsible management … Board encourages management to promote a culture that incorporates risk management into our corporate strategy and day-to-day business operations
424B4
lzpdkk2ke0
1 Jul 21
Prospectus supplement with pricing info
4:31pm
DEF 14A
fhdpavvya 7qlodl1pc
27 Apr 21
Definitive proxy
4:15pm
10-K
hy8lvqzolfj
23 Mar 21
Annual report
4:26pm
424B4
gnacvfk sl
19 Oct 20
Prospectus supplement with pricing info
5:21pm
S-1
5mbcig596ig8k1mya20n
25 Sep 20
IPO registration
5:27pm
DRS
z3clpazrd6bjyltf
26 Aug 20
Draft registration statement
12:00am
- Prev
- 1
- Next